EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 115 filers reported holding EPIZYME INC in Q3 2019. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | +83.3% | 15,287 | -18.9% | 0.00% | – |
| Q1 2022 | $12,000 | -53.8% | 18,843 | +78.1% | 0.00% | – |
| Q4 2021 | $26,000 | -52.7% | 10,580 | -1.5% | 0.00% | – |
| Q3 2021 | $55,000 | -40.2% | 10,736 | -3.2% | 0.00% | – |
| Q2 2021 | $92,000 | -8.9% | 11,088 | -4.2% | 0.00% | – |
| Q1 2021 | $101,000 | -99.7% | 11,576 | -99.6% | 0.00% | -100.0% |
| Q4 2020 | $28,974,000 | -12.2% | 2,667,977 | -3.5% | 0.03% | -23.8% |
| Q3 2020 | $32,990,000 | -10.5% | 2,765,292 | +20.4% | 0.04% | -16.0% |
| Q2 2020 | $36,875,000 | -45.4% | 2,296,110 | -47.3% | 0.05% | -12.3% |
| Q1 2020 | $67,564,000 | +3.8% | 4,356,168 | +64.6% | 0.06% | -27.8% |
| Q4 2019 | $65,108,000 | +190.1% | 2,646,668 | +21.6% | 0.08% | +172.4% |
| Q3 2019 | $22,442,000 | +6.4% | 2,175,688 | +29.4% | 0.03% | -32.6% |
| Q2 2019 | $21,094,000 | +4.0% | 1,680,830 | +2.6% | 0.04% | -6.5% |
| Q1 2019 | $20,289,000 | – | 1,637,470 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |